Holen Sie sich die Stockscreener-App
88.09
1.00%
0.87
Schlusskurs vom Vortag:
$87.22
Offen:
$87.27
24-Stunden-Volumen:
836.77K
Relative Volume:
0.55
Marktkapitalisierung:
$11.79B
Einnahmen:
$2.51B
Nettoeinkommen (Verlust:
$185.56M
KGV:
65.74
EPS:
1.34
Netto-Cashflow:
$517.59M
1W Leistung:
+0.32%
1M Leistung:
-2.30%
6M Leistung:
+40.29%
1J Leistung:
+4.71%
1-Tages-Spanne:
$87.27
$89.84
1-Wochen-Bereich:
$86.06
$89.84
52-Wochen-Spanne:
$51.79
$101.40
Globus Medical Inc Stock (GMED) Company Profile
Firmenname
Globus Medical Inc
Sektor
Branche
Telefon
610-930-1800
Adresse
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
88.09 | 11.67B | 2.51B | 185.56M | 517.59M | 1.34 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Hochstufung | Needham | Hold → Buy |
| 2026-01-27 | Eingeleitet | TD Cowen | Buy |
| 2025-11-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-11-07 | Hochstufung | Truist | Hold → Buy |
| 2025-10-28 | Fortgesetzt | Stifel | Hold |
| 2025-05-27 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-01-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-19 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-30 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-02-10 | Herabstufung | Loop Capital | Buy → Hold |
| 2023-02-10 | Herabstufung | Needham | Buy → Hold |
| 2023-02-10 | Herabstufung | Truist | Buy → Hold |
| 2023-02-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-28 | Eingeleitet | Wells Fargo | Overweight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-29 | Eingeleitet | Loop Capital | Buy |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2020-12-08 | Eingeleitet | Citigroup | Buy |
| 2020-10-20 | Eingeleitet | Stifel | Hold |
| 2020-08-06 | Bestätigt | Needham | Buy |
| 2020-08-06 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Eingeleitet | Northland Capital | Market Perform |
| 2020-07-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Bestätigt | Needham | Buy |
| 2020-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-12-12 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-05-24 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Bestätigt | Needham | Buy |
| 2019-02-28 | Hochstufung | UBS | Neutral → Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-27 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Bestätigt | Needham | Buy |
| 2018-04-04 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Globus Medical Inc Aktie (GMED) Neueste Nachrichten
Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call - marketscreener.com
Globus Medical (GMED) to Report Q4 Results: Wall Street Expects Earnings Growth - Finviz
Madison Asset Management LLC Sells 58,971 Shares of Globus Medical, Inc. $GMED - MarketBeat
Will Globus Medical Inc. stock maintain dividend yieldTrade Exit Report & Weekly Breakout Stock Alerts - mfd.ru
Globus Medical (GMED) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term - Yahoo Finance
Can Globus Medical Inc. reach all time highs this year - mfd.ru
Candriam S.C.A. Sells 43,909 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical Inc (NYSE:GMED): A Prime Example of Affordable Growth - ChartMill
Globus Medical (GMED) Valuation Check After Mixed Short Term Returns And 16.6% Undervaluation View - Sahm
Thrivent Financial for Lutherans Sells 194,537 Shares of Globus Medical, Inc. $GMED - MarketBeat
Foresight Group Ltd Liability Partnership Raises Stake in Globus Medical, Inc. $GMED - MarketBeat
How Globus Medical’s Robotics and Digitization Push Will Impact Globus Medical (GMED) Investors - Sahm
New York State Common Retirement Fund Sells 77,412 Shares of Globus Medical, Inc. $GMED - MarketBeat
Here's Why Globus Medical (GMED) is a Strong Value Stock - Yahoo Finance
Globus Medical (GMED) Valuation Check After Mixed Short Term Share Performance - Yahoo Finance
2 Reasons to Watch GMED and 1 to Stay Cautious - Yahoo Finance
Is Globus Medical (GMED) Pricing Fair After The Recent Healthcare Sector Reassessment? - Sahm
Van Berkom & Associates Inc. Purchases 48,906 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical IncA (NYSE:GMED) Shows Strong Fundamentals and Technical Setup for Growth - ChartMill
Globus Medical, Inc. (GMED): Analyst Consensus and Growth Potential Highlight an 18% Upside - DirectorsTalk Interviews
Zacks Research Lifts Earnings Estimates for Globus Medical - MarketBeat
At US$90.68, Is It Time To Put Globus Medical, Inc. (NYSE:GMED) On Your Watch List? - 富途牛牛
Dip Buying: Will Globus Medical Inc benefit from government policy2025 Risk Factors & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
CEO Change: Can Origin Materials Inc outperform under higher oil prices2025 AllTime Highs & Growth Focused Entry Point Reports - baoquankhu1.vn
Assessing Globus Medical (GMED) Valuation After Investor Letter Highlights Reaccelerating Spine Growth And Integration Progress - Sahm
Needham upgrades Globus Medical stock to Buy on margin expansion By Investing.com - Investing.com Canada
Needham Upgrades Globus Medical to Buy From Hold, Sets $112 Price Target - marketscreener.com
The Analyst Verdict: Globus Medical In The Eyes Of 13 Experts - Benzinga
This Southwest Airlines Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday - Benzinga
Analyst Upgrade: Needham Upgrades GMED to 'Buy' Rating | GMED St - GuruFocus
Globus Medical (NYSE:GMED) Upgraded by Needham & Company LLC to "Buy" Rating - MarketBeat
Needham Upgrades Globus Medical (GMED) - Nasdaq
TD Cowen Upgrades Globus Medical (NYSE:GMED) to "Strong-Buy" - MarketBeat
Cambiar Investors LLC Sells 55,919 Shares of Globus Medical, Inc. $GMED - MarketBeat
Here's Why Globus Medical (GMED) is a Strong Momentum Stock - sharewise.com
Y Intercept Hong Kong Ltd Cuts Position in Globus Medical, Inc. $GMED - MarketBeat
Here’s What Lifted Globus Medical (GMED) in Q4 - Insider Monkey
TD Cowen Initiates Coverage on Globus Medical With Buy Rating, $110 Price Target - marketscreener.com
Globus Medical, Inc. $GMED Shares Sold by Strs Ohio - MarketBeat
Globus Medical stock operating in a buy zone after strong preliminary results - MSN
Is Globus Medical (GMED) Attractively Priced After Recent P/E And DCF Valuation Signals - Yahoo Finance
Globus Medical, Inc. (GMED) Stock Analysis: Exploring A Robust 15% Potential Upside - DirectorsTalk Interviews
TD Cowen assumes coverage on Globus Medical stock with Buy rating - Investing.com Canada
What Catalysts Are Quietly Shifting The Story For Globus Medical (GMED)? - Yahoo Finance
Here's Why Globus Medical (GMED) is a Strong Growth Stock - Yahoo Finance
Universal Beteiligungs und Servicegesellschaft mbH Cuts Stock Holdings in Globus Medical, Inc. $GMED - MarketBeat
Will Globus Medical (GMED) beat estimates again in its next earnings report? - MSN
Lightrock Netherlands B.V. Increases Stock Position in Globus Medical, Inc. $GMED - MarketBeat
Is Globus Medical (GMED) Pricing Reflect Its DCF Upside And Mixed P/E Signals? - Sahm
Aug Update: What is Globus Medical Incs TAM Total Addressable Market2025 Market Sentiment & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Finanzdaten der Globus Medical Inc-Aktie (GMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.33%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):